Enzo Life Sciences, Inc.

Finding the right antibody can be difficult and costly.? Enzo understands this, and is happy to offer you a 25% discount* on Enzo Antibodies when you place your order on our website!? And now, all Enzo branded antibodies are covered by our new Worry-Free Guarantee**, enabling you to test any of them in your experiments with zero risk. Start Saving Today >? https://lnkd.in/eqcifz9R? ? #ScientistsEnablingScientists #Antibodies #WorryFreeGuarantee #WhyDoYouResearch #ScientistsEnablingSavings #EnablingConsistency #EnablingSpecificity #EnablingSensitivity #HappyLabHappyLife? ? * Offer valid through 1/31/2025. Enzo Antibody orders must be placed on Enzo.com to qualify for discount. Offer valid only on Enzo Antibodies. Place Promo Code AB25WEB2024 in the comment section at checkout to receive your 25% discount. See terms and conditions for offer details.? ** Terms and? Conditions do apply. Please check our Website.?

LifeSensors, Inc specializes in protein homeostasis and ubiquitin pathway research.? For neuroscience research, LifeSensors offers cutting-edge tools such as ubiquitin affinity matrices, SUMO detection kits, and proprietary PROTAC-based technologies, to help investigate the role of protein misfolding and degradation in neuronal health and disease, which are crucial for studying diseases such as Alzheimer’s and Parkingson’s.? ?? Explore LifeSensors Products >> https://lnkd.in/ePsmUmbC

Thank you to the Long Island Herald for honoring Enzo’s Patricia Eckert, Chief Financial Officer, with the Top Chief Officers Award!? ? Patty has been a results-driven leader at Enzo for 7 years, and is a valued member of our executive management team.? Congratulations to Patty and all of the deserving top executives who were recognized for their excellence in leadership and for driving innovation that shapes our community’s future.?? ? #ScientistsEnablingScientists? #EnablingLeadership? #EnablingInnovation? #STEM? #EnablingLongIsland Herald Community Newspapers

Accelerate your drug discovery with our robust, integrated contract services. ? Our custom compound services offer innovative, flexible solutions - ranging from complete analytical support and rigorous quality oversite with professional reporting, to intended use-driven manufacturing at our ISO-certified facility.? Accelerate your drug discovery program or complement your research strategy with our extensive selection of ready-to-use activity assays, detection and labeling kits, ELISA kits, and stand-alone small molecules.? ?? Explore our Enabling Solutions? >> https://lnkd.in/ee4VesKr #ScientistsEnablingScientist #DrugDiscovery #Services?

Drive your neuroscience research forward with our robust, integrated analytical services? Accelerate your research strategy with our extensive selection of ready-to-use activity assays, detection and labeling kits, ELISA kits, and stand-alone small molecules.?? Our comprehensive compound screening approaches integrate customizable compound libraries with the functional analysis required for target discovery and validation. Incorporate additional specializations, like our Custom Protein, Antibody, or Oligo Services, into your research program.? ? Explore our Enabling Solutions >>?? https://lnkd.in/eju_Bxv6? ?? #ScientistsEnablingScientist #neurosciences #services?

Join us to explore the forefront of tissue analysis with IMAI, an ETH Zurich and University Hospital Zurich spin-off leading innovation in 3D histology. CEO and co-founder, Dr. Catto will introduce IMAI and demonstrate how their rapid, automated approach is transforming research and pathology by adding a third dimension to tissue visualization, uncovering insights previously unattainable with 2D methods. She will delve into the technology and highlight impactful applications in cancer diagnostics, preclinical research, and neuroscience, including an exciting collaboration with Enzo. Additionally, Dr Catto will touch on partnership opportunities and their business model. This session provides a unique chance to see how IMAI is accelerating tissue analysis for faster, more profound insights. The webinar will conclude with an interactive Q&A session. Save the date: December 10th, 3:00 PM GMT Secure you seat by registering today: https://lnkd.in/ezDna9Dj #ScientistsEnablingScientists #neuroscience #webinar #thoughtleadership #EnablingLearning #EnablingOptimization

Celebrating Academic Excellence at the Farmingdale State College President's Gala Enzo was honored to attend and support the 2024 Farmingdale State College annual President's Gala. We deeply value our partnership with Farmingdale State College. Enzo proudly supports FSC’s continued commitment to academic excellence, providing superior educational opportunities on Long Island. We are happy to partner with FSC in enabling a brighter future for students in our community, and beyond. Here’s to FSC’s outstanding accomplishments, and to our continued partnership with a shared commitment to education! #EnablingAcademics #CommunityPartnership #FarmingdalePresidentsGala #FSC #EnablingPartnerships

The authors of this research identify a library of 3-amino-1,2,4-triazine derivatives that inhibit PDK activity and use Enzo’s MITO-ID? Membrane Potential Detection Kit in human pancreatic PSN-1 cells, to further characterize the mechanisms by which they work. They aim to further test these derivative compounds for efficacy as therapeutics against KRAS-mutant pancreatic ductal adenocarcinoma. Read the paper > https://lnkd.in/e8AnhiHN Learn more about Enzo’s product > https://lnkd.in/eTnJyf66 #ScientistsEnablingScientists #drugdiscovery #livecell #cellularassay

A seminal study by Sutcliffe et al. highlights unexpected results that the liver, and not the brain, may be the primary source of β-amyloid deposits in the brain associated with Alzheimer’s disease. In the cited study, scientists from the Scripps Research Institute and ModGene, LLC used a mouse model for Alzheimer’s disease to identify genes that influence the amount of β-amyloid accumulation in the brain. It can be hypothesized that alterations of the liver’s degradative capabilities potentially contribute to β-amyloid levels in the brain. Using a β-amyloid degradation assay, Maarouf et al. (2018) demonstrated that β-amyloid degradation rates were lower in Alzheimer’s disease subjects when compared with non-demented control subjects. Looking further at the expression of potential β-amyloid-degrading enzymes, they showed that cathepsin D and insulin-degrading enzyme, but not neprysilin, were significantly down-regulated in Alzheimer’s disease subjects. Although lower β-amyloid degradation rates could be a consequence of the disease rather than a contributing cause, these results do highlight the need to further investigate the role of β-amyloid produced in tissues other than the brain in the pathogenesis of Alzheimer’s disease. This application note shows how Enzo’s PROTEOSTAT? Aggresome detection kit was used to contribute to the pursuit of this research. Read the Application Note >> https://lnkd.in/eXJYPptu #ScientistsEnablingScientists #neuroscience

Our antibody conjugation services combine years of engineering expertise in labeling and detection with a broad selection of proprietary and commercial labels and cross-linking strategies, ensuring you receive personalized, reliable solutions to support your project.? ? Solve unique technical challenges with our robust labeling technologies or explore our scalable and bulk production options.? ? Read More >> https://lnkd.in/eVh5MMZG ? #ScientistsEnablingScientists #services?